Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Oncology department celebrates 50 years of excellence
2017-09-07

  Description: Oncology photo Tags: Oncology, cancer, University of the Free State, UFS, Dr Alicia Sherriff, Faculty of Health Sciences

The UFS Department of Oncology celebrated 50 years of
existence. Prof Louis Goedhals says that the department
is like a family that will carry and support you.
Photo: Wendy Ruth
 



South Africa could see an increase of 78% in the number of cancer cases by 2030 and from a global perspective, a 75% increase is expected, increasing the total incidence of all new cancer cases from 12.7 million in 2008 to 22.2 million by 2030, according to a recent study published by medical journal Lancet. According to the Cancer Association of South Africa (CANSA), more than 100 000 South Africans are diagnosed each year. It is rather comforting that the University of the Free State’s (UFS) Faculty of Health Sciences has an Oncology department that has been fighting cancer for 50 years. 

Excellence over the decades 
The 50-year celebration of the Department of Oncology took place at the UFS Centenary Complex on the Bloemfontein Campus on 19 August 2017. The auspicious event was attended by UFS Faculty of Health Sciences registrars, radiation oncology radiographers and professional nurses who had trained in the department over the past 50 years, as well as the current departmental staff.

Dr Alicia Sherriff, Head of the Department of Oncology welcomed the dignitaries and thanked everyone for their attendance and dedication to the department, Prof Louis Goedhals, the oldest surviving head of department, gave a summary of the 50 years. He said once you were involved with this department you became part of a family that would carry and support you. Memories were shared and friendships rekindled. The message of this department that stood the test of time was: “To cure sometimes, to relieve often, to comfort always … and to bring hope”.

UFS dignitaries reveled in the moment 

Among the special guests were the Rector and Vice Chancellor, Prof Francis Petersen, Prof Gert van Zyl, Dean of Faculty of Health Sciences; the Free State MEC for Health Mr Butana Komphela, and CEO of Universitas Hospital Dr Marcus Molokomme, were invited. The function was well attended by personnel, graduates from as far as Portugal, and dignitaries from the university. There was a sense of unity and belonging among all the attendees and enthusiastic catching up over the years that have passed.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept